NEC's new AI-driven drug discovery business

NEC Corp. Senior Vice President Osamu Fujikawa (R) and Eric Quemeneur, executive vice president in charge of research and development at French biotechnology company Transgene SA, shake hands at a press conference in Tokyo on May 27, 2019. The two companies will jointly develop tailor-made vaccines for new types of cancer using artificial intelligence, with clinical tests to begin this year. (Kyodo) ==Kyodo